Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Investing activities | ||
| Purchase of investments | (195,612) | (65,063) |
| Proceeds from maturities of investments | 59,739 | 42,497 |
| Purchase of property and equipment | (687) | (167) |
| Payments made for additions to intangible assets | (35,000) | — |
| Net cash used in investing activities | (171,560) | (22,733) |
| Financing activities | ||
| Proceeds from issuance of convertible notes, net of issuance costs of $17,565 | 672,435 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s capex?
- Mirum Pharmaceuticals, Inc. (MIRM) reported capex of $23K in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s capex changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s capex decreased by 81.7% year-over-year, from $126K to $23K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s capex?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s capex has grown at a 241.3% compound annual growth rate (CAGR), from $24K to $954K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Mirum Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude